These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34358714)

  • 1. Liver-Specific Deletion of Mouse CTCF Leads to Hepatic Steatosis via Augmented PPARγ Signaling.
    Choi Y; Song MJ; Jung WJ; Jeong H; Park S; Yang B; Lee EC; Joo JS; Choi D; Koo SH; Kim EK; Nam KT; Kim HP
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1761-1787. PubMed ID: 34358714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-100 overexpression attenuates high fat diet induced weight gain, liver steatosis, hypertriglyceridemia and development of metabolic syndrome in mice.
    Smolka C; Schlösser D; Hohnloser C; Bemtgen X; Jänich C; Schneider L; Martin J; Pfeifer D; Moser M; Hasselblatt P; Bode C; Grundmann S; Pankratz F
    Mol Med; 2021 Sep; 27(1):101. PubMed ID: 34488621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis.
    Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y
    J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.
    Hajri T; Zaiou M; Fungwe TV; Ouguerram K; Besong S
    Cells; 2021 May; 10(6):. PubMed ID: 34072832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte-specific Nrf2 deficiency mitigates high-fat diet-induced hepatic steatosis: Involvement of reduced PPARγ expression.
    Li L; Fu J; Liu D; Sun J; Hou Y; Chen C; Shao J; Wang L; Wang X; Zhao R; Wang H; Andersen ME; Zhang Q; Xu Y; Pi J
    Redox Biol; 2020 Feb; 30():101412. PubMed ID: 31901728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.
    Lee J; Song JH; Park JH; Chung MY; Lee SH; Jeon SB; Park SH; Hwang JT; Choi HK
    Exp Mol Med; 2023 Jan; 55(1):143-157. PubMed ID: 36609599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation is independent of steatosis in a murine model of steatohepatitis.
    Wang W; Xu MJ; Cai Y; Zhou Z; Cao H; Mukhopadhyay P; Pacher P; Zheng S; Gonzalez FJ; Gao B
    Hepatology; 2017 Jul; 66(1):108-123. PubMed ID: 28220523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet.
    Xia SF; Le GW; Wang P; Qiu YY; Jiang YY; Tang X
    Nutrients; 2016 Dec; 8(12):. PubMed ID: 27973423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
    Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
    Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
    Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
    Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory Galectin-3 promotes hepatic steatosis via regulation of the PPARγ/CD36 signaling pathway.
    Yu H; Yang F; Zhong W; Jiang X; Zhang F; Ji X; Xue M; Qiu Y; Yu J; Hu X; Chen J; Bao Z
    Cell Signal; 2021 Aug; 84():110043. PubMed ID: 33991615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells.
    Zhao NQ; Li XY; Wang L; Feng ZL; Li XF; Wen YF; Han JX
    World J Gastroenterol; 2017 Nov; 23(43):7705-7715. PubMed ID: 29209111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
    Liu J; Tang T; Wang GD; Liu B
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
    [No Abstract]   [Full Text] [Related]  

  • 17. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
    Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
    Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis exacerbates the progression of fatty liver disease via CD36-PPARγ pathway.
    Ahn JS; Yang JW; Oh SJ; Shin YY; Kang MJ; Park HR; Seo Y; Kim HS
    BMB Rep; 2021 Jun; 54(6):323-328. PubMed ID: 34078528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ attenuates hepatic inflammation and oxidative stress of non‑alcoholic steatohepatitis via modulating the miR‑21‑5p/SFRP5 pathway.
    Zhang X; Deng F; Zhang Y; Zhang X; Chen J; Jiang Y
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34558644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.